Published in J Clin Microbiol on April 30, 2014
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin Infect Dis (2016) 3.58
Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care (2015) 1.30
Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections. Clin Microbiol Infect (2015) 0.89
Diagnosis of periprosthetic joint infection using alpha-defensin test or multiplex-PCR: ideal diagnostic test still not found. Int Orthop (2017) 0.87
Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management. Biomed Res Int (2014) 0.84
Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Crit Care (2016) 0.75
The Unyvero P55 'sample-in, answer-out' pneumonia assay: A performance evaluation. Biomol Detect Quantif (2017) 0.75
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
The origins and the future of microfluidics. Nature (2006) 16.24
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Ventilator-associated pneumonia. Am J Respir Crit Care Med (2002) 9.63
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Microfluidic diagnostic technologies for global public health. Nature (2006) 7.08
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax (2009) 5.23
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis (2010) 2.79
Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax (1999) 2.47
FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One (2011) 2.38
Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med (1996) 2.23
Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med (2003) 2.20
The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest (1998) 2.15
De-escalation therapy in ventilator-associated pneumonia. Crit Care Med (2004) 1.85
Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS (2005) 1.10